PL378556A1 - Nienukleozydowe inhibitory odwrotnej transkryptazy - Google Patents
Nienukleozydowe inhibitory odwrotnej transkryptazyInfo
- Publication number
- PL378556A1 PL378556A1 PL378556A PL37855604A PL378556A1 PL 378556 A1 PL378556 A1 PL 378556A1 PL 378556 A PL378556 A PL 378556A PL 37855604 A PL37855604 A PL 37855604A PL 378556 A1 PL378556 A1 PL 378556A1
- Authority
- PL
- Poland
- Prior art keywords
- reverse transcriptase
- transcriptase inhibitors
- nucleoside reverse
- nucleoside
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44797403P | 2003-02-18 | 2003-02-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL378556A1 true PL378556A1 (pl) | 2006-05-02 |
Family
ID=32908518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL378556A PL378556A1 (pl) | 2003-02-18 | 2004-02-17 | Nienukleozydowe inhibitory odwrotnej transkryptazy |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7241794B2 (pl) |
| EP (1) | EP1597235B1 (pl) |
| JP (1) | JP4608480B2 (pl) |
| KR (1) | KR100776093B1 (pl) |
| CN (1) | CN100389109C (pl) |
| AR (1) | AR043195A1 (pl) |
| AT (1) | ATE370124T1 (pl) |
| BR (1) | BRPI0407591A (pl) |
| CA (1) | CA2515151C (pl) |
| CL (1) | CL2004000270A1 (pl) |
| DE (1) | DE602004008227T2 (pl) |
| ES (1) | ES2291854T3 (pl) |
| MX (1) | MXPA05008748A (pl) |
| PL (1) | PL378556A1 (pl) |
| RU (1) | RU2305680C2 (pl) |
| TW (1) | TW200423930A (pl) |
| WO (1) | WO2004074257A1 (pl) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1622876A1 (en) * | 2003-05-07 | 2006-02-08 | Pfizer Products Inc. | Cannabinoid receptor ligands and uses thereof |
| JP4993407B2 (ja) | 2004-08-04 | 2012-08-08 | 大正製薬株式会社 | トリアゾール誘導体 |
| UA87884C2 (uk) * | 2004-12-03 | 2009-08-25 | Мерк Энд Ко., Инк. | Безводна кристалічна калієва сіль інгібітора віл-інтегрази |
| CN101415691B (zh) | 2006-02-03 | 2011-12-14 | 大正制药株式会社 | 三唑衍生物 |
| EP1988081B1 (en) | 2006-02-06 | 2012-10-17 | Taisho Pharmaceutical Co., Ltd | Binding inhibitor of sphingosine-1-phosphate |
| AU2007216034B2 (en) * | 2006-02-14 | 2011-08-04 | Kumiai Chemical Industry Co., Ltd. | Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound |
| CL2007002105A1 (es) * | 2006-07-21 | 2008-02-22 | Hoffmann La Roche | Compuestos derivados de 2-[3-(3-cianofenoxi)(fenoxi o fenilsulfanil)]-n-fenil acetamida, inhibidores de la transcriptasa inversa del vih; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar u |
| ES2360893T3 (es) * | 2006-08-16 | 2011-06-10 | F. Hoffmann-La Roche Ag | Inhibidores no nucleósidos de la transcriptasa inversa. |
| EP2142520A1 (en) | 2007-03-29 | 2010-01-13 | F. Hoffmann-Roche AG | Non-nucleoside reverse transcriptase inhibitors |
| US8048898B2 (en) | 2007-08-01 | 2011-11-01 | Taisho Pharmaceutical Co., Ltd | Inhibitor of binding of S1P1 |
| AU2008340422B2 (en) * | 2007-12-21 | 2014-06-19 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
| DE102008015033A1 (de) * | 2008-03-17 | 2009-09-24 | Aicuris Gmbh & Co. Kg | Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| PL2924034T3 (pl) * | 2010-03-30 | 2017-07-31 | Merck Canada Inc. | Kompozycja farmaceutyczna zawierająca nienukleozydowy inhibitor odwrotnej transkryptazy |
| JP5722891B2 (ja) | 2010-07-15 | 2015-05-27 | 大日本住友製薬株式会社 | ピラゾール化合物 |
| EP2508511A1 (en) * | 2011-04-07 | 2012-10-10 | Laboratoire Biodim | Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| US9505728B2 (en) | 2012-03-09 | 2016-11-29 | Inception 2, Inc. | Triazolone compounds and uses thereof |
| JP2015520240A (ja) | 2012-06-20 | 2015-07-16 | ヴァンダービルト ユニバーシティー | Ｍｇｌｕｒ５受容体のアロステリック調節剤としての置換二環式アルコキシピラゾール類似体 |
| US8901125B2 (en) | 2012-06-20 | 2014-12-02 | Vanderbilt University | Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors |
| JO3470B1 (ar) | 2012-10-08 | 2020-07-05 | Merck Sharp & Dohme | مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv |
| JP6404230B2 (ja) | 2012-12-20 | 2018-10-10 | インセプション ２、 インコーポレイテッド | トリアゾロン化合物およびその使用 |
| CN105579440A (zh) | 2013-09-06 | 2016-05-11 | 因森普深2公司 | 三唑酮化合物及其应用 |
| BR112016022722B8 (pt) | 2014-04-01 | 2023-11-21 | Merck Sharp & Dohme | Composto, composição farmacêutica que o comprende e uso do mesmo |
| US20170298055A1 (en) | 2014-09-17 | 2017-10-19 | Ironwood Pharmaceuticals, Inc. | sGC STIMULATORS |
| JP2017527604A (ja) | 2014-09-17 | 2017-09-21 | アイアンウッド ファーマシューティカルズ インコーポレイテッド | ｓＧＣ刺激剤 |
| WO2016149311A1 (en) * | 2015-03-19 | 2016-09-22 | E I Du Pont De Nemours And Company | Fungicidal pyrazoles |
| WO2018001973A1 (en) * | 2016-06-29 | 2018-01-04 | Laboratorios Del Dr. Esteve S.A. | Pyrazole derivatives having activity against pain |
| CN110818636A (zh) * | 2019-11-29 | 2020-02-21 | 河北科技大学 | 一种化合物或其盐及其应用和合成方法 |
| CN115677585B (zh) * | 2022-10-31 | 2024-03-19 | 上海群力化工有限公司 | 一种甲醛吡唑衍生物的合成工艺 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2200316C (en) | 1994-09-26 | 2004-09-21 | Hirohiko Sugimoto | Imidazole derivative |
| DE19734664A1 (de) * | 1997-08-11 | 1999-02-18 | Bayer Ag | (Hetero)Aryloxypyrazole |
| GB0016787D0 (en) * | 2000-07-07 | 2000-08-30 | Pfizer Ltd | Compounds useful in therapy |
| US20030008841A1 (en) * | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
| GB0024795D0 (en) * | 2000-10-10 | 2000-11-22 | Hoffmann La Roche | Pyrazole derivatives for the treatment of viral diseases |
| GB0028484D0 (en) * | 2000-11-22 | 2001-01-10 | Hoffmann La Roche | Imidazolone derivatives for the treatment of viral diseases |
| NZ529403A (en) * | 2001-04-10 | 2005-06-24 | Pfizer | Pyrazole derivatives for treating HIV |
| GB0113524D0 (en) * | 2001-06-04 | 2001-07-25 | Hoffmann La Roche | Pyrazole derivatives |
-
2004
- 2004-02-12 TW TW093103358A patent/TW200423930A/zh unknown
- 2004-02-16 CL CL200400270A patent/CL2004000270A1/es unknown
- 2004-02-17 PL PL378556A patent/PL378556A1/pl not_active Application Discontinuation
- 2004-02-17 BR BRPI0407591-9A patent/BRPI0407591A/pt not_active IP Right Cessation
- 2004-02-17 KR KR1020057015085A patent/KR100776093B1/ko not_active IP Right Cessation
- 2004-02-17 ES ES04711607T patent/ES2291854T3/es not_active Expired - Lifetime
- 2004-02-17 RU RU2005128832/04A patent/RU2305680C2/ru active
- 2004-02-17 CN CNB2004800044061A patent/CN100389109C/zh not_active Expired - Fee Related
- 2004-02-17 AT AT04711607T patent/ATE370124T1/de not_active IP Right Cessation
- 2004-02-17 DE DE602004008227T patent/DE602004008227T2/de not_active Expired - Lifetime
- 2004-02-17 CA CA2515151A patent/CA2515151C/en not_active Expired - Fee Related
- 2004-02-17 WO PCT/EP2004/001477 patent/WO2004074257A1/en active IP Right Grant
- 2004-02-17 MX MXPA05008748A patent/MXPA05008748A/es active IP Right Grant
- 2004-02-17 JP JP2006500034A patent/JP4608480B2/ja not_active Expired - Fee Related
- 2004-02-17 AR ARP040100477A patent/AR043195A1/es not_active Application Discontinuation
- 2004-02-17 EP EP04711607A patent/EP1597235B1/en not_active Expired - Lifetime
- 2004-02-18 US US10/781,373 patent/US7241794B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20040192666A1 (en) | 2004-09-30 |
| EP1597235A1 (en) | 2005-11-23 |
| KR20050105471A (ko) | 2005-11-04 |
| RU2305680C2 (ru) | 2007-09-10 |
| WO2004074257A1 (en) | 2004-09-02 |
| AR043195A1 (es) | 2005-07-20 |
| RU2005128832A (ru) | 2006-04-27 |
| CA2515151C (en) | 2010-11-30 |
| CN1751028A (zh) | 2006-03-22 |
| AU2004213134A1 (en) | 2004-09-02 |
| DE602004008227D1 (de) | 2007-09-27 |
| ES2291854T3 (es) | 2008-03-01 |
| CL2004000270A1 (es) | 2005-02-04 |
| BRPI0407591A (pt) | 2006-02-14 |
| MXPA05008748A (es) | 2005-09-20 |
| CN100389109C (zh) | 2008-05-21 |
| US7241794B2 (en) | 2007-07-10 |
| TW200423930A (en) | 2004-11-16 |
| JP2006515339A (ja) | 2006-05-25 |
| DE602004008227T2 (de) | 2008-05-15 |
| JP4608480B2 (ja) | 2011-01-12 |
| EP1597235B1 (en) | 2007-08-15 |
| ATE370124T1 (de) | 2007-09-15 |
| CA2515151A1 (en) | 2004-09-02 |
| KR100776093B1 (ko) | 2007-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL378556A1 (pl) | Nienukleozydowe inhibitory odwrotnej transkryptazy | |
| TWI372619B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| HK1080849A1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| ZA200803174B (en) | N-phenyl phenylacetamide non-nucleoside reverse transcriptase inhibitors | |
| IL180495A0 (en) | Benzyltriazolone compounds as nin-nucleoside reverse transcriptase inhibitors | |
| IL199103A0 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| IL188615A0 (en) | Hiv reverse transcriptase inhibitors | |
| AU2003269628A1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| IL196655A0 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| EP2076492A4 (en) | NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS | |
| HK1111155A1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| EP1756091A4 (en) | NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| IL152819A0 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| ZA200900071B (en) | Non-nucleoside reverse transcriptase inhibitors | |
| EP1899340A4 (en) | NON-NUCLEOSIDIC REVERSE TRANSCRIPTASE INHIBITORS | |
| ZA200800185B (en) | Hiv reverse transcriptase inhibitors | |
| HRP20040886A2 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| ZA200605395B (en) | Non-nucleotide reverse transcriptase inhibitors | |
| SI1294720T1 (sl) | Nenukleozidni inhibitorji reverzne transkriptaze | |
| AU2002355614A1 (en) | Non-nucleoside reverse transcriptase inhibitors | |
| DK1373267T3 (da) | Non-nucleoside revers transkriptase-inhibitorer | |
| GB0329869D0 (en) | Inhibitors | |
| GB0300607D0 (en) | Inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |